• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

固定系数和指数在预测人体药物清除率中的作用:从一两个物种进行的预测有多准确?

Role of fixed coefficients and exponents in the prediction of human drug clearance: how accurate are the predictions from one or two species?

作者信息

Mahmood Iftekhar

机构信息

Office of Blood Review & Research, Center for Biologic Evaluation and Research, Food & Drug Administration, 1451 Rockville Pike, Maryland, USA.

出版信息

J Pharm Sci. 2009 Jul;98(7):2472-93. doi: 10.1002/jps.21597.

DOI:10.1002/jps.21597
PMID:19025899
Abstract

Pharmacokinetic (PK) interspecies scaling is generally conducted using PK data from at least three animal species but three animal species may not be always available. In a recent manuscript, Tang et al. have described the methods to predict human drug clearance using one or two animal species. The authors claim that their proposed methods are better than the rule of exponents (ROE) which uses at least three animal species for the prediction of human drug clearance. A thorough examination of Tang et al.'s manuscript indicates that the data analysis may not be accurate. Considering that Tang et al.'s method may be of value, the objective of this study was to extend Tang et al.'s proposed methods for drugs given both intravenously and orally. The results of this study indicate that human drug clearance cannot be predicted with reasonable accuracy for most of the drugs by Tang et al.'s proposed methods and the accuracy of the prediction obtained from the ROE remains more accurate (based on average fold-error) than the one or two-species methods. This manuscript also clarifies some incorrect views regarding ROE presented by Tang et al. in their manuscript.

摘要

药代动力学(PK)种间缩放通常使用至少三种动物物种的PK数据进行,但并非总是能获得三种动物物种的数据。在最近的一篇手稿中,Tang等人描述了使用一两种动物物种预测人体药物清除率的方法。作者声称,他们提出的方法比使用至少三种动物物种预测人体药物清除率的指数规则(ROE)更好。对Tang等人手稿的全面审查表明,数据分析可能不准确。考虑到Tang等人的方法可能有价值,本研究的目的是扩展Tang等人提出的静脉内和口服给药药物的方法。本研究结果表明,对于大多数药物,Tang等人提出的方法无法以合理的准确性预测人体药物清除率,并且从ROE获得的预测准确性(基于平均倍数误差)仍然比一两种物种的方法更准确。本手稿还澄清了Tang等人在其手稿中提出的关于ROE的一些错误观点。

相似文献

1
Role of fixed coefficients and exponents in the prediction of human drug clearance: how accurate are the predictions from one or two species?固定系数和指数在预测人体药物清除率中的作用:从一两个物种进行的预测有多准确?
J Pharm Sci. 2009 Jul;98(7):2472-93. doi: 10.1002/jps.21597.
2
Prediction of human drug clearance from two species: a comparison of several allometric methods.从两种物种预测人体药物清除率:几种比例预测法的比较。
J Pharm Sci. 2010 Mar;99(3):1601-13. doi: 10.1002/jps.21926.
3
Interspecies prediction of human drug clearance based on scaling data from one or two animal species.基于一两种动物物种的标度数据对人体药物清除率进行种间预测。
Drug Metab Dispos. 2007 Oct;35(10):1886-93. doi: 10.1124/dmd.107.016188. Epub 2007 Jul 23.
4
Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.从临床前信息预测人体药代动力学:定量预测方法的比较准确性
J Clin Pharmacol. 2009 May;49(5):513-33. doi: 10.1177/0091270009333209. Epub 2009 Mar 19.
5
Prediction of human drug clearance from animal data: application of the rule of exponents and 'fu Corrected Intercept Method' (FCIM).从动物数据预测人体药物清除率:指数规则和“游离分数校正截距法”(FCIM)的应用
J Pharm Sci. 2006 Aug;95(8):1810-21. doi: 10.1002/jps.20650.
6
Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance.基于体内动物药代动力学数据的人体药代动力学预测的综合评估,第 2 部分:清除率。
J Clin Pharmacol. 2013 Feb;53(2):178-91. doi: 10.1177/0091270012440282. Epub 2013 Jan 24.
7
A mathematical description of the functionality of correction factors used in allometry for predicting human drug clearance.用于预测人体药物清除率的异速生长中校正因子功能的数学描述。
Drug Metab Dispos. 2005 Sep;33(9):1294-6. doi: 10.1124/dmd.105.004135. Epub 2005 May 26.
8
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.制药研究和制造商协会(PhRMA)与美国疾病控制与预防中心(CPCDC)关于人体药代动力学预测模型的倡议,第3部分:人体清除率预测方法的比较评估
J Pharm Sci. 2011 Oct;100(10):4090-110. doi: 10.1002/jps.22552. Epub 2011 May 3.
9
Comparative evaluation of US Food and Drug Administration and pharmacologically guided approaches to determine the maximum recommended starting dose for first-in-human clinical trials in adult healthy men.比较评估美国食品和药物管理局和药理学指导方法,以确定成年健康男性首次人体临床试验的最大推荐起始剂量。
J Clin Pharmacol. 2011 Dec;51(12):1655-64. doi: 10.1177/0091270010387429. Epub 2011 Mar 17.
10
Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR.种间比例缩放:预测人体胆汁清除率并与 QSPKR 进行比较。
Biopharm Drug Dispos. 2012 Jan;33(1):1-14. doi: 10.1002/bdd.1761. Epub 2012 Jan 24.

引用本文的文献

1
All You Need to Know About Allometric Scaling: An Integrative Review on the Theoretical Basis, Empirical Evidence, and Application in Human Pharmacology.关于异速生长比例关系你需要知道的一切:对理论基础、实证证据及其在人类药理学中的应用的综合综述
Clin Pharmacokinet. 2025 Feb;64(2):173-192. doi: 10.1007/s40262-024-01444-6. Epub 2024 Dec 7.
2
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc.DNDI-6174 是一种针对细胞色素 bc 的内脏利什曼病的临床前候选药物。
Sci Transl Med. 2023 Dec 13;15(726):eadh9902. doi: 10.1126/scitranslmed.adh9902.
3
Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans.
从临床前动物外推纳米材料的处置和药代动力学的研究工具。
Theranostics. 2019 May 18;9(11):3365-3387. doi: 10.7150/thno.34509. eCollection 2019.
4
Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths.超重和肥胖人群的体重会影响卡泊芬净的药代动力学变异性:三分之二或四分之三以上的分形幂律特征。
Antimicrob Agents Chemother. 2013 May;57(5):2259-64. doi: 10.1128/AAC.01490-12. Epub 2013 Mar 4.
5
Applications of human pharmacokinetic prediction in first-in-human dose estimation.人体药代动力学预测在首次人体剂量估算中的应用。
AAPS J. 2012 Jun;14(2):262-81. doi: 10.1208/s12248-012-9332-y. Epub 2012 Mar 10.
6
Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?从非临床数据预测治疗性抗体的人体药代动力学:我们学到了什么?
MAbs. 2011 Jan-Feb;3(1):61-6. doi: 10.4161/mabs.3.1.13799. Epub 2011 Jan 1.